目的 为规范医院外科围术期抗菌药物预防性应用与管理,探索合理干预途径。方法 选取普外科甲状腺手术、乳腺手术、腹股沟疝修补术3种Ⅰ类切口手术,2011-07至2011-09的出院病例为干预前组(基线调查组),2012-07至2012-09,以及2013-07至2013-09的出院病例为干预后1、2组,对干预前后3组预防使用抗菌药物的合理性进行干预对照研究。结果 共调查病历348份,2011-2013年抗菌药物预防使用率依次为96.2%、33.6%、6.9%( P＜ 0. 05)。3种Ⅰ类切口手术3年的抗菌药物预防使用率分别为:甲状腺100%、3.8%、2.9%;腹股沟疝91.8%、55.5%、12.8%;乳腺100%、61.9%、8.7%。结论 通过制订干预措施能有效提高医院抗菌药物临床合理应用水平。
Abstract
Objective To standardise the antimicrobial prophylaxis(AMP)during perioperative period of surgical operations in this hospital and explore reasonable measures of intervention. Methods Patients who underwent three type I incisions in general surgery: including thyroid, breast and inguinal hermia repair surgery, were recruited. The patients dismissed from July to September of year 2011 were taken as pre-intervention group, and those in year 2012 and 2013 as post-intervention group. The rationaly of antibiolic prophylaxis between pre-intervention group and post-intervention group were compared control study. Results A total of 348 cases were investigated. The utilization rate of antimicrobial prophylaxis from year 2011 to 2013 were 96.2%, 33.6%, 6.9%, respectively. Utilization rates of antimicrobial prophylaxis in the three type I incision surgery during the three years were as follows: 100%, 3.8%, and 2.9% for thyroid surgery; 91.8%, 55.5%, and 12.8% for inguinal hermia repair surgery; 100%, 61.9%, and 8.7% for breast surgery. Conclusions The intervening measures improve effectively the reasonable use of antibiotics in clinic.
关键词
Ⅰ类切口手术 /
围术期 /
抗菌药物 /
预防应用 /
干预
Key words
type I incision surgery /
perioperative period /
antimicrobics /
prophylaxis /
intervention
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 卫生部,国家中医药管理局,总后卫生部.抗菌药物临床应用指导原则[S].卫发[2004]285号.
[2] 中华人民共和国卫生部.卫生部办公厅关于做好全国抗菌药物临床应用专项整治活动的通知[S].北京:中华人民共和国卫生部,2011.
[3] 陈 宁,颜 青,郑迎东,等.技术干预对广东省三甲医院的3种外科手术预防性应用抗菌药物合理性的影响[J].中国临床药理学杂志,2011,27(11):880-882.
[4] Kijima T, Masuda H, Yoshida S, et al. Antimicrobial prophylaxis is not necessary in clean category minimally invasive surgery for renal and adrenal tumors: a prospective study of 373 consecutive patients[J]. Urology,2012,80(3):570-575.
[5] 王国权,李 丹,吴 琼.Ⅰ类手术切口抗菌药物使用干预效果分析[J].中华医院感染学杂志,2013,23(20):5032-5034.
[6] 王 玉,薛苏冬,张 茜,等.294例普外科清洁手术围手术期预防用抗菌药物分析[J].抗感染药学,2012,9(4):312-314.
[7] 徐小刚,李光辉.抗感染药物在外科领域的预防性应用指南[J].中国抗感染化疗杂志,2005,5(3):180-183.
[8] Togo Y, Tanaka S, Kanematsu A, et al. Antimicrobial prophylaxis to prevent perioperative infection in urological surgery: a multicenter study[J].Infect Chemother,2013,19(6):1093-1101.
[9] Hansen E, Belden K, Silibovsky R, et al. Perioperative Antibiotics[J]. Arthroplasty,2014,29(2):29-48.
[10] 梅 昕,徐 莺,刘 婧,等.某院Ⅰ类手术切口围术期抗菌药物应用分析[J].武警医学, 2013,24(2):159-162.
[11] 张玉军,陈 英,杨周生.广西地区三级甲等医院3种清洁手术预防用抗菌药物干预前后的调查分析[J].中国医院药学杂志,2012,32(18):1486-1489.
[12] 刘振华,仲 华,吕娟丽.围术期应用抗菌药物的合理性及干预前后的对比[J].武警医学,2013,24(11):966-969.
[13] 曾玉琴,朱建勇,柯宗萍,等. 2型糖尿病合并肺部感染病原菌分布及药物敏感性[J]. 华南国防医学杂志,2012,26(4):336-338.
[14] 悦姣星,黄 海. 做好医院感染控制工作的理性思考[J]. 华南国防医学杂志,2013,27(7):524-525.
PDF(723 KB)
